{
    "clinical_study": {
        "@rank": "3127", 
        "arm_group": {
            "arm_group_label": "PTA catheter (Iris)", 
            "arm_group_type": "Experimental"
        }, 
        "brief_summary": {
            "textblock": "The purpose of this study is to determine whether the peripheral balloon dilatation catheter\n      (trade name: Iris) is safe an effective in PTA procedure."
        }, 
        "brief_title": "Effectiveness and Safety Study of Peripheral Balloon Dilatation Catheter in Percutaneous Transluminal Angioplasty(PTA) Procedure", 
        "completion_date": {
            "#text": "October 2013", 
            "@type": "Anticipated"
        }, 
        "condition": "Peripheral Arterial Disease", 
        "condition_browse": {
            "mesh_term": [
                "Peripheral Arterial Disease", 
                "Peripheral Vascular Diseases"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Age: 18 yrs - 80 yrs.\n\n          -  patients with iliac and / or femoral artery atherosclerotic lesions\n\n          -  Rutherford grade of 1-5;\n\n          -  Target lesion stenosis\u226570% (visual estimation) (proportion of Trans-Atlantic\n             Inter-Society Consensus(TASC) B, C and D grade lesions not less than 60% )\n\n          -  Patients being able to understand the purpose of the test, and being volunteered to\n             participate in and sign the informed consent.\n\n        Exclusion Criteria:\n\n          -  Patients not suitable for receiving interventional surgeries of lower limb arteries\n             for treatment;\n\n          -  Patients require intervention of lesions besides unilateral iliac and femoral artery\n             lesions at the same time;\n\n          -  Patients have been involved in clinical trials of other drugs or medical devices\n             within the past three months;\n\n          -  Patient is unable or unwilling to participate in this trial;\n\n          -  Patients with serious heart and brain, liver and other vital organs failure;\n\n          -  Patients with life expectancy less than 6 months;\n\n          -  Pregnant women."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "80 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "167", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "April 28, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01849601", 
            "org_study_id": "acotec-01"
        }, 
        "intervention": {
            "arm_group_label": "PTA catheter (Iris)", 
            "intervention_name": "percutaneous transluminal angioplasty balloon catheter", 
            "intervention_type": "Device", 
            "other_name": [
                "PTA catheter", 
                "trade name: Iris"
            ]
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "May 7, 2013", 
        "location": {
            "contact": {
                "email": "pla301dml@vip.sina.com", 
                "last_name": "Wei Guo, Dr"
            }, 
            "facility": {
                "address": {
                    "city": "Beijing", 
                    "country": "China", 
                    "zip": "100853"
                }, 
                "name": "Wei Guo"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "China"
        }, 
        "number_of_arms": "1", 
        "official_title": "A Prospective, Multicenter and Single-arm Target Value Clinical Study on the Efficacy and Safety of Peripheral Balloon Dilatation Catheter in PTA Procedure", 
        "overall_contact": {
            "email": "pla301dml@vip.sina.com", 
            "last_name": "wei guo, Dr"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "China: Food and Drug Administration", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "July 2013", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "successfully pass lesion(s)\nsuccessfully dilate lesion(s)( diameter of balloon reach at least 90% of the nominal diameter)\nsuccessfully retrieve\nThe definition of technical success rate of PTA procedure is that, all of the above 3 point are successful", 
            "measure": "technical success rate of PTA procedure", 
            "safety_issue": "No", 
            "time_frame": "instant"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01849601"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "relevant balloon complications occurred during procedure(failure of balloon inflation, rupture of the balloon, failure of balloon deflation, failure of withdrawn, catheter fracture, etc.).\nRelevant major vascular complications occurred during procedure (rupture of blood vessels and acute vascular occlusion caused by dilation).", 
            "measure": "safety assessment", 
            "safety_issue": "Yes", 
            "time_frame": "day 2 to day 10 after procedure or hospital discharge"
        }, 
        "source": "Acotec Scientific Co., Ltd", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Acotec Scientific Co., Ltd", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "December 2012", 
        "study_design": "Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "November 2012"
    }
}